Quarterly Report • Feb 26, 2024
Quarterly Report
Open in ViewerOpens in native device viewer

ELEASE


Hod Hasharon (Israel) 25 February 2024 - Singapore Exchange Mainboard and Tel Aviv Exchange listed Sarine Technologies Ltd ("Sarine" and along with its subsidiaries "the Group") (U77:SI; SARN.TA), a worldwide leader in the development, manufacturing, marketing and sale of precision technology products for the evaluation, planning, processing, measurement, grading and trading of diamonds and gems, announces its financial results for the twelve months ended 31 December 2023.
Significant economic headwinds in the major U.S. and China markets stifled the diamond industry in 2023. In the primary U.S. market concerns of a looming recession dampened consumer sentiment for much of the year, easing towards year-end. In China, the second most important market for diamond jewellery, negative news relating primarily to the real-estate market and fears of possible banking insolvencies impacted consumer spending and continue to do so. In addition, the rapid expansion of the LGD segment in the U.S. market in 2022 and 2023 disrupted demand for natural diamonds.
In the last months of 2023, the interest rate outlook in the U.S. improved, and this contributed to more buoyant consumer confidence in the critical year-end holiday season. Overall holiday spending was some 5% higher over the preceding year. Significantly, the market disruption caused by LGD may have peaked, as the growth trend of LGD adoption slowed in the second half of 2023. This may have been due to the sharp decline in LGD wholesale and, more importantly, retail prices, thus reducing retailers' profits and margins, along with the growing consumer realisation that not all LGD are necessarily "green". While it may be too early to call this a new trend, the slowdown could indicate that the natural diamond and LGD segments of the diamond jewellery market are reaching a new equilibrium.
In another year filled with challenges, Group revenue for FY2023 declined 27% to US\$43.0 million. At the segmental level, capital equipment sales fell by about 50% while as recurring revenues declined only 3%. The half year segmental for H2 2023 recorded a 62% decrease in capital equipment sales, offset by an approximate 4% increase in recurring revenues due to the addition of GCAL. In May 2023, the Group acquired a 70% stake in the gemmological laboratory grading business and certain assets of the New-York based Gem Certification & Assurance Lab, Inc. (GCAL). Recurring revenues are expected to continue growing in FY2024 from the expansion of our grading services to India and adoption of our new pay-per-use services for natural and LGD stones optimal planning.
On lower revenue and a change in the revenue mix that includes GCAL, gross profit margin dropped to 64% in FY2023 from 69% in FY2022 with a corresponding decrease in gross profit from US\$40.6 million in FY2022 to US\$27.4 million in FY2023. Overall expenses fell in H2 2023 due to costcutting steps taken, and the reduction will accelerate into FY2024 as the Group continues to right size its expenses in FY2024. With the decline in gross profit, the Group reported a loss of US\$2.8 million for FY2023, as compared to a profit of US\$8.8 million for FY2022.
The Group delivered only 27 Galaxy® -family inclusion mapping systems in FY2023. As of December 31, 2023, our installed base was 830 systems.



The outlook for interest rates has improved from late 2023. Most central banks have stopped further rate increases, and there is growing expectation that interest rates could start falling later in 2024. Within the diamond industry, conditions have improved from the challenges of H2 2023. Year-end sales have reduced the inventory of polished natural diamonds and the substantial reduction in the prices of rough diamonds in January 2024 has improved the profit margins of manufacturers. The market disruption caused by LGD may have peaked in 2023, and any recovery of the natural diamond industry in 2024 will benefit our traditional businesses of capital equipment sales and Galaxy® scanning.
The Group's new services have received encouraging responses from industry participants, and we expect recurring revenue to continue growing from continued adoption in 2024. Our recently launched Most Valuable Plan™ (MVP) paradigm for the optimal planning of rough diamonds 40 points and below will be extended to rough diamonds of up to 90 points in the second half of 2024. MVP has been proven to create significant added value for our customers, and its immediate addressable market will be the 27 million rough stones of these sizes scanned on our installed base of Meteorite™ Plus systems in 2023. Also slated for release in 2024 is the Meteor™ Plus inclusion scanning system for stones up to 90 points, a segment in which an additional 6 million stones were scanned in 2023. These innovations should drive both legacy planning and Galaxy® -family scanning systems capital equipment sales in 2024, in addition to their generation of a new recurring revenue stream.
In any new equilibrium for the diamond industry, LGD are expected to account for a meaningful portion of the diamond jewellery market. To adequately address this segment, we have adopted GCAL's work procedures, and our LGD-focused GCAL by Sarine grading lab in India commenced operations in January this year. Adaptation of our AI-derived grading technologies to LGD will enable further expansion of this service. We aim to attain an 8-10% share of the estimated US\$ 100 million LGD grading segment in FY2024. This month, we launched the utilisation of our industry-leading rough planning technologies on LGD on a pay-per-carat service basis. Initial responses have been positive with recurring revenue already being generated. Additional LGD manufacturers, currently testing the offering, may be adopting it soon as well.
The AutoScan™ Plus and Sarine Diamond Journey™ combined solution provides a cost-effective means to address the environmental, social and governance (ESG) issues that concern retailers, especially luxury brands and new customers will be added in 2024. The G7 countries have implemented tighter sanctions on Russian-sourced diamonds, banning importation of polished diamonds over half a carat in stages throughout 2024. If their enforcement is predicated on a "verifiable" source traceability system, we are confident that the AutoScan™ Plus and Sarine Diamond Journey™ can provide a scalable (an estimated 3 million plus diamonds of the relevant sizes are polished annually) accurate and cost-effective means to meet the mandated requirements with minimal overhead or disruption to the diamond value chain.
This press release is to be read in conjunction with Sarine's FY2023 results released to the Singapore Exchange on 25 February 2024.



Established in 1988, Sarine Technologies Ltd. is a worldwide leader in the development and manufacturing of advanced modeling, analysis, evaluation, planning, processing, finishing, grading and trading systems for diamonds. Sarine products include the Galaxy® family of inclusion and tension mapping systems, rough diamond planning and optimisation technologies, laser cutting and shaping tools, laser-marking, inscription and fingerprinting equipment, automated (AI-derived) Clarity, Color, Cut and light performance grading systems and traceability, visualisation and retailing services. Sarine systems have become standard tools in every modern manufacturing plant, properly equipped gemology lab and diamond appraisal business, and are essential aids for diamond polishers, dealers and retailers. For more information about Sarine and its products and services, visit http://www.sarine.com
Cyrus Capital Consulting Mr. Lee Teong Sang Tel: +65-96339035 [email protected]
| Ms. | Romy | Gakh-Baram | |||
|---|---|---|---|---|---|
| Tel: | +972-9-7903500 | ||||
| [email protected] |

(Incorporated in Israel) (Registration Number: 51-133220-7)
| Table of Contents | ||||
|---|---|---|---|---|
| A. Condensed Consolidated and Company Statements of Financial Position |
1 | |||
| B. Condensed Consolidated Interim Statements of Profit or Loss and Other Comprehensive Income |
2 | |||
| C. Condensed Consolidated and Company Statements of Changes in Equity |
3 | |||
| D. Condensed Consolidated Statements of Cash Flows | 4 | |||
| E. Notes to the Condensed Interim Financial Statements | 5 | |||
| F. Other Information Required by Listing Rule 7.2 | 12 |
| Group | Company | ||||
|---|---|---|---|---|---|
| 2023 | 2022 | 2023 | 2022 | ||
| US\$ thousands | |||||
| Assets | |||||
| Property, plant and equipment | 11,637 | 10,431 | 1,827 | 1,395 | |
| Right-of-use assets | 6,032 | 3,918 | 3,014 | 3,751 | |
| Intangible assets | 7,752 | 2,051 | -- | 70 | |
| Long-term trade receivables | 573 | 1,006 | 276 | 653 | |
| Investment in subsidiaries | -- | -- | 43,576 | 36,022 | |
| Long-term income tax receivable | 500 | 500 | -- | -- | |
| Deferred tax assets | 568 | 499 | -- | -- | |
| Total non-current assets | 27,062 | 18,405 | 48,693 | 41,891 | |
| Inventories | 10,520 | 6,859 | 7,324 | 4,388 | |
| Trade receivables | 14,652 | 21,476 | 5,819 | 6,733 | |
| Other current assets | 1,383 | 2,496 | 699 | 1,553 | |
| Short-term investments (bank deposits) | 634 | 10,684 | -- | 9,627 | |
| Cash and cash equivalents | 22,351 | 25,307 | 7,644 | 17,216 | |
| Total current assets | 49,540 | 66,822 | 21,486 | 39,517 | |
| Total assets | 76,602 | 85,227 | 70,179 | 81,408 | |
| Equity | |||||
| Share capital* | -- | -- | -- | -- | |
| Share premium and reserves | 35,264 | 34,490 | 35,264 | 34,490 | |
| Translation reserve | (4,249) | (4,217) | (4,249) | (4,217) | |
| Dormant shares, at cost | (5,183) | (4,829) | (5,183) | (4,829) | |
| Retained earnings | 34,488 | 41,652 | 34,488 | 41,652 | |
| Total equity | 60,320 | 67,096 | 60,320 | 67,096 | |
| Liabilities | |||||
| Long-term lease liabilities | 5,392 | 3,557 | 2,847 | 3,524 | |
| Financial instrument, see Note 10 | 1,727 | -- | -- | -- | |
| Employee benefits | 153 | 194 | 143 | 184 | |
| Total non-current liabilities | 7,272 | 3,751 | 2,990 | 3,708 | |
| Trade payables | 1,781 | 3,220 | 1,848 | 2,544 | |
| Other payables | 5,655 | 8,220 | 4,127 | 7,139 | |
| Current lease liabilities | 1,240 | 812 | 687 | 682 | |
| Current tax payable | 46 | 1,769 | -- | -- | |
| Warranty provision | 288 | 359 | 207 | 239 | |
| Total current liabilities | 9,010 | 14,380 | 6,869 | 10,604 | |
| Total liabilities | 16,282 | 18,131 | 9,859 | 14,312 | |
| Total equity and liabilities | 76,602 | 85,227 | 70,179 | 81,408 |
* No par value
| Group Six Months Ended December 31, |
Group Year ended December 31, |
|||||
|---|---|---|---|---|---|---|
| 2023 US\$ thousands |
2022 | change % |
2023 US\$ thousands |
2022 | change % |
|
| Revenue | 19,213 | 27,591 | (30.4) | 42,944 | 58,763 | (26.9) |
| Cost of Sales | (8,101) | (9,209) | (12.0) | (15,573) | (18,140) | (14.2) |
| Gross profit | 11,112 | 18,382 | (39.5) | 27,371 | 40,623 | (32.6) |
| Research and development expenses | (4,232) | (4,481) | (5.6) | (8,597) | (8,675) | (0.9) |
| Sales and marketing expenses | (6,256) | (6,168) | 1.4 | (12,843) | (12,425) | 3.4 |
| General and administrative expenses | (3,863) | (4,236) | (8.8) | (7,775) | (8,525) | (8.8) |
| (Loss) Profit from operations | (3,239) | 3,497 | NM | (1,844) | 10,998 | NM |
| Net finance income | 154 | 264 | (41.7) | 576 | 337 | 70.9 |
| (Loss) Profit before income tax | (3,085) | 3,761 | NM | (1,268) | 11,335 | NM |
| Income tax expense | 670 | 1,508 | (55.6) | 1,534 | 2,537 | (39.5) |
| (Loss) Profit for the period | (3,755) | 2,253 | NM | (2,802) | 8,798 | NM |
| Other comprehensive income (loss) | ||||||
| Remeasurement of defined benefit plan |
37 | 50 | (26.0) | 37 | 50 | (26.0) |
| Foreign currency translation differences from foreign operations |
(87) | (574) | (84.8) | (32) | (1,321) | (97.6) |
| Total comprehensive (loss) income for the period |
(3,805) | 1,729 | NM | (2,797) | 7,527 | NM |
| Earnings per share Basic (losses) earnings per share (US |
(1.08) | 0.64 | NM | (0.80) | 2.51 | NM |
| cents) Diluted (losses) earnings per share (US cents) |
(1.08) | 0.64 | NM | (0.80) | 2.51 | NM |
| Share capital* |
Share premium and reserves |
Translation reserve |
Retained earnings |
Dormant shares |
Total | |
|---|---|---|---|---|---|---|
| Group and Company | US\$ thousands | |||||
| Balance at January 1, 2022 | -- | 34,014 | (2,896) | 43,368 | (3,935) | 70,551 |
| Profit for the year ended December 31, 2022 |
-- | -- | -- | 8,798 | -- | 8,798 |
| Other comprehensive income (loss) for the year ended December 31, 2022 |
-- | 50 | (1,321) | -- | -- | (1,271) |
| Dormant shares, acquired at cost (3,119,500 shares) |
-- | -- | -- | -- | (894) | (894) |
| Share-based payment expenses | -- | 264 | -- | -- | -- | 264 |
| Exercise of options | -- | 162 | -- | -- | -- | 162 |
| Dividend paid | -- | -- | -- | (10,514) | -- | (10,514) |
| Balance at December 31, 2022 | -- | 34,490 | (4,217) | 41,652 | (4,829) | 67,096 |
| Loss for the year ended December 31, 2023 |
-- | -- | -- | (2,802) | -- | (2,802) |
| Other comprehensive income (loss) for the year ended December 31, 2023 |
-- | 37 | (32) | -- | -- | 5 |
| Dormant shares, acquired at cost (1,558,200 shares) |
-- | -- | -- | -- | (354) | (354) |
| Share-based payment expenses | -- | 323 | -- | -- | -- | 323 |
| Capital infusion by minority shareholder in consolidated |
||||||
| subsidiary | -- | 343 | -- | -- | -- | 343 |
| Exercise of options | -- | 71 | -- | -- | -- | 71 |
| Dividend paid | -- | -- | -- | (4,362) | -- | (4,362) |
| Balance at December 31, 2023 | -- | 35,264 | (4,249) | 34,488 | (5,183) | 60,320 |
* No par value
| Group | ||
|---|---|---|
| 2023 | 2022 | |
| US\$ thousands | ||
| Cash flows (used in) from operating activities | ||
| (Loss) Profit for the year | (2,802) | 8,798 |
| Adjustments for: | ||
| Share-based payment expenses | 323 | 264 |
| Income tax expense | 1,534 | 2,537 |
| Depreciation of property, plant & equipment and right-of-use assets | 2,933 | 2,380 |
| Amortisation of intangible assets | 456 | 193 |
| Net finance expense | (535) | 169 |
| Revaluation of lease liabilities from exchange rate differences | (144) | (630) |
| Changes in working capital | ||
| Inventories | (3,661) | 421 |
| Trade receivables | 7,257 | 1,279 |
| Other current assets | 1,113 | (895) |
| Trade payables | (1,439) | 896 |
| Other liabilities | (2,661) | (235) |
| Employee benefits | (4) | (81) |
| Income tax paid | (3,326) | (2,198) |
| Net cash (used in) from operating activities | (956) | 12,898 |
| Cash flows from (used in) investing activities | ||
| Acquisition of property, plant and equipment | (1,483) | (986) |
| Acquisition of consolidated subsidiary, see Note 10 | (5,741) | -- |
| Proceeds from realisation of property, plant and equipment | 56 | 51 |
| Short-term investments, net | 10,050 | (1,629) |
| Interest received | 799 | 388 |
| Net cash from (used in) investing activities | 3,681 | (2,176) |
| Cash flows used in financing activities | ||
| Proceeds from exercise of share options | 71 | 162 |
| Purchase of Company's shares by the Company | (354) | (894) |
| Capital infusion by minority shareholder in consolidated subsidiary | 343 | -- |
| Dividends paid | (4,362) | (10,514) |
| Payment of lease liabilities | (1,115) | (970) |
| Interest paid | (240) | (150) |
| Net cash used in financing activities | (5,657) | (12,366) |
| Net decrease in cash and cash equivalents | (2,932) | (1,644) |
| Cash and cash equivalents at beginning of year | 25,307 | 27,358 |
| Effect of exchange rate fluctuations on cash and cash equivalents | (24) | (407) |
| Cash and cash equivalents at end of year | 22,351 | 25,307 |
Sarine Technologies Ltd. (hereinafter "Sarine" or the "Company") is a company domiciled in Israel. The address of the Company's registered office is 4 Haharash Street, Hod Hasharon 4524075, Israel. The condensed interim financial statements of the Company, as at December 31, 2023 and for the six months and year ended December 31, 2023, comprise the Company and its subsidiaries (together referred to as the "Group" and individually as "Group entities"). The Company was incorporated on November 8, 1988. On April 8, 2005, the Company was admitted to the Main Board list of the Singapore Exchange Securities Trading Ltd. and on July 5, 2021, the Company dual listed its shares for trading on the Tel Aviv Stock Exchange.
The condensed interim financial statements have been prepared in accordance with International Financial Reporting Standards (IFRS). The condensed interim financial statements for the six months and year ended December 31, 2023 have been prepared in accordance with IAS 34 Interim Financial Reporting.
The condensed interim financial statements were authorised for issue by the Company's Board of Directors on February 25, 2024.
The condensed interim financial statements have been prepared on the historical cost basis except for the following material items in the condensed interim statement of financial position:
These condensed interim financial statements are presented in United States (US) dollars, or US\$, which is the Company's functional currency. The US dollar is the currency that represents the principal economic environment in which the Company and most Group entities operate. All financial information presented in US dollars has been rounded to the nearest thousand, except where otherwise indicated.
The preparation of condensed interim financial statements in conformity with IFRS requires management to make judgments, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets and liabilities, income and expenses. Certain accounting estimates used in the preparation of the Group's condensed interim financial statements may require management to make assumptions regarding circumstances and events that involve considerable uncertainty. Management prepares these estimates on the basis of past experience, known facts, external circumstances, and reasonable assumptions. Actual results may differ from these estimates.
Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimates are revised and in any future periods affected.
The accounting policies applied in these condensed interim financial statements for the six months and year ended December 31, 2023 are the same as those applied by the Company in audited financial statements for the year ended December 31, 2022.
The Group is a worldwide leader in the development, manufacturing, marketing and sale of precision technology products for the planning, processing, evaluation and measurement of diamonds and gems. India is the principal market for these products. In accordance with IFRS 8, the Group determines and presents operating segments based on the information that is provided internally to the CEO, who is the Group's chief operating decision maker. The measurement of operating segment results is generally consistent with the presentation of the Group's condensed interim statements of comprehensive income. The Group operates in only one operating segment. Presented below are revenues broken out by geographic distribution (India, Africa, Europe, USA, Israel and Other).
| Group | ||||
|---|---|---|---|---|
| Six months ended December 31, | ||||
| US\$ thousands | ||||
| Region | 2023 | 2022 | \$ change | % |
| India | 8,976 | 14,362 | (5,386) | (37.5) |
| Africa | 2,367 | 6,706 | (4,339) | (64.7) |
| Europe | 1,002 | 1,402 | (400) | (28.5) |
| USA | 3,798 | 308 | 3,490 | 1,133.1 |
| Israel | 789 | 1,475 | (686) | (46.5) |
| Other* | 2,281 | 3,338 | (1,057) | (31.7) |
| Total | 19,213 | 27,591 | (8,378) | (30.3) |
| Group Year ended December 31, |
|||||
|---|---|---|---|---|---|
| US\$ thousands | |||||
| Region | 2023 | 2022 | \$ change | % | |
| India | 22,036 | 30,309 | (8,273) | (27.3) | |
| Africa | 6,336 | 13,692 | (7,356) | (53.7) | |
| Europe | 2,730 | 3,502 | (772) | (22.0) | |
| USA | 5,147 | 842 | 4,305 | 511.3 | |
| Israel | 1,803 | 2,227 | (424) | (19.0) | |
| Other* | 4,892 | 8,191 | (3,299) | (40.3) | |
| Total | 42,944 | 58,763 | (15,819) | (26.9) |
* Primarily Asia, excluding India
| Group | ||||
|---|---|---|---|---|
| Six months ended December 31, | Year ended December 31, | |||
| US\$ thousands | ||||
| Composition | 2023 | 2022 | 2023 | 2022 |
| Sale of products1 | 12,378 | 24,051 | 31,397 | 50,785 |
| Maintenance & services2 | 6,835 | 3,540 | 11,547 | 7,978 |
| Total | 19,213 | 27,591 | 42,944 | 58,763 |
1 Includes Galaxy® family recurring revenues associated with customer-owned machines.
The Group calculates the period income tax expense using the tax rate that would be applicable to the expected total annual earnings. The major components of income tax expense in the condensed interim statements of profit or loss and other comprehensive income are:
| Group | ||||
|---|---|---|---|---|
| Six months ended December 31, | Year ended December 31, | |||
| US\$ thousands | ||||
| 2023 | 2022 | 2023 | 2022 | |
| Current tax expense | 472 | 1,484 | 1,338 | 2,518 |
| Taxes in respect of previous years |
259 | (9) | 267 | (22) |
| Deferred tax (income) expense |
(61) | 33 | (71) | 41 |
| Total income tax expense | 670 | 1,508 | 1,534 | 2,537 |
| December 31, 2023 | June 30, 2023 | December 31, 2022 | |
|---|---|---|---|
| No. of shares | No. of shares | No. of shares | |
| Authorised: | |||
| Ordinary shares of no par value | 2,000,000,000 | 2,000,000,000 | 2,000,000,000 |
| Issued and fully paid: | |||
| Ordinary shares of no par value | 356,812,335 | 356,812,335 | 356,447,895 |
| Dormant shares (out of the issued and fully paid share capital): |
|||
| Ordinary shares of no par value | (9,067,900) | (7,566,600) | (7,509,700) |
| Total number of issued shares (excluding dormant shares) |
347,744,435 | 349,245,735 | 348,938,195 |
For the six months ended December 31, 2023, no share options were exercised into ordinary shares. For the six months ended December 31, 2023, the Company purchased 1,501,300 of its ordinary shares at an aggregate cost of US\$ 337,000. For the year ended December 31, 2023, 364,440 share options were exercised into ordinary shares. For the year ended December 31, 2023, the Company purchased 1,558,200 of its ordinary shares at an aggregate cost of US\$ 354,000. There was no sale, transfer, disposal, cancellation and/or use of treasury shares by the Company.
As at December 31, 2023 the total number of issued shares excluding dormant shares was 347,744,435 (as at December 31, 2022- 348,938,195). As at December 31, 2023 the total number of dormant shares was 9,067,900 (as at December 31, 2022- 7,509,700). In accordance with Israeli Companies Law, Company shares that have been acquired and are held by the Company are dormant shares (treasury shares in Singaporean terms) as long as the Company holds them, and, as such, they do not bear any rights until they are transferred to a third party. The issued and fully paid shares as at December 31, 2023, June 30, 2023 and December 31, 2022 included 9,067,900, 7,566,600 and 7,509,700 dormant shares, respectively.
For the year ended December 31, 2023, the Company paid US\$ 4.4 million in dividends (an interim US\$ 0.9 million in September 2023 and a US\$ 3.5 million final dividend, in respect of FY2022, in May 2023). See also Note 11 – Subsequent Events.
| Average exercise price in US\$ per share |
Options | |
|---|---|---|
| At January 1, 2023 | 0.572 | 15,529,930 |
| Granted | 0.331 | 4,925,000 |
| Cancelled | 1.100 | (3,016,779) |
| Exercised | 0.195 | (364,440) |
| At December 31, 2023 | 0.424 | 17,073,711 |
During the year ended December 31, 2023, the Company granted 4,925,000 options to employees and directors under the Company's 2015 Option Plan, with vesting conditions of one to three years and a contractual life of six years. The options vest subject to service-based conditions and performance-based conditions, relating to sales and other strategic targets.
The Company measured the fair value of the share options granted using a lattice-based valuation model. The following assumptions under this method were used for the share options granted during the year ended December 31, 2023: weighted average expected volatility of: 47.00%; weighted average risk-free interest rates (in US dollar terms) of 2.87%; dividend yield of 6.26%. The weighted average fair value of the share options granted during year ended December 31, 2023 using the model was US\$ 0.090 per share option.
The calculation of basic loss per share for the six months ended December 31, 2023 was based on the loss attributable to ordinary shareholders of US\$ 3,755,000 (six months ended December 31, 2022 – profit of US\$ 2,253,000) and a weighted average number of ordinary shares outstanding of 348,980,234 (six months ended December 31, 2022 – 350,001,649). The calculation of basic loss per share for the year ended December 31, 2023 was based on the loss attributable to ordinary shareholders of US\$ 2,802,000 (2022 profit of -- US\$ 8,798,000) and a weighted average number of ordinary shares outstanding of 348,841,849 (2022 – 350,518,378), calculated as follows:
| Six months ended December 31, | Year ended December 31, | |||
|---|---|---|---|---|
| 2023 | 2022 | 2023 | 2022 | |
| Basic (losses) earnings per share (US cents) |
(1.08) | 0.64 | (0.80) | 2.51 |
| Issued ordinary shares | ||||
| at beginning of period | 349,245,735 | 350,710,075 | 348,938,195 | 351,090,280 |
| Effect of share options exercised | -- | 536,874 | 225,577 | 400,081 |
| Effect of dormant shares purchased | (265,501) | (1,245,300) | (321,923) | (971,983) |
| Weighted average number of ordinary shares during period |
348,980,234 | 350,001,649 | 348,841,849 | 350,518,378 |
The calculation of diluted earnings per share for the six months ended December 31, 2023 was based on the loss attributable to ordinary shareholders of US\$ 3,755,000 (six months ended December 31, 2022 profit of -- US\$ 2,253,000) and a weighted average number of ordinary shares outstanding after adjustment for the effects of all dilutive potential ordinary shares of 348,980,234 (six months ended December 31, 2022 -350,100,509). The calculation of diluted earnings per share for the year ended December 31, 2023 was based on the loss attributable to ordinary shareholders of US\$ 2,802,000 (2022 profit of -- US\$ 8,798,000) and a weighted average number of ordinary shares outstanding after adjustment for the effects of all dilutive potential ordinary shares of 348,841,849 (2022 - 350,799,554), calculated as follows:
| Six months ended December 31, | Year ended December 31, | |||
|---|---|---|---|---|
| 2023 | 2022 | 2023 | 2022 | |
| Diluted (loss) earnings per share (US cents) |
(1.08) | 0.64 | (0.80) | 2.51 |
| Weighted average number of ordinary shares (basic) Effect of share options on issue |
348,980,234 -- |
350,001,649 98,860 |
348,841,849 -- |
350,518,378 281,176 |
| Weighted average number of ordinary shares (diluted) during period |
348,980,234 | 350,100,509 | 348,841,849 | 350,799,554 |
The average market value of the Company's ordinary shares for purposes of calculating the dilutive effect of share options was based on quoted market prices for the period that the options were outstanding.
| Group | Company | |||
|---|---|---|---|---|
| December 31, | December 31, | |||
| 2023 | 2022 | 2023 | 2022 | |
| US\$ thousands | ||||
| Right-of-use assets | 6,032 | 3,918 | 3,014 | 3,751 |
| Current lease liabilities | 1,240 | 812 | 687 | 682 |
| Long-term lease liabilities | 5,392 | 3,557 | 2,847 | 3,524 |
| Total lease liabilities | 6,632 | 4,369 | 3,534 | 4,206 |
Maturity analysis of the Group's and Company's lease liabilities as at December 31, 2023.
| Group | Company | ||
|---|---|---|---|
| US\$ thousands | |||
| Less than one year | 1,240 | 687 | |
| One to five years | 4,092 | 2,544 | |
| More than five years | 1,300 | 303 | |
| Total lease liabilities | 6,632 | 3,534 |
The Group has lease agreements with respect to office facilities mainly in Israel and India. The Group also has lease agreements in respect to vehicles in Israel. In measurement of the lease liabilities, the Group discounted lease payments using the nominal incremental borrowing rate as at the lease inception, or at January 1, 2019 for leases in effect prior to December 31, 2018. In April 2021, the Group executed a renegotiated lease agreement for its leased office space at the Group's headquarters in Israel. Under the terms of the agreement, the leased space was downsized by approximately 30% and the financial terms were improved. Under the revised terms, the lease was extended for a period of four years, with an option for a second four-year period.
In May 2023, the Company's indirect wholly-owned subsidiary, Sarine North America, Inc. (the "Purchaser"), closed an asset purchase agreement to acquire the business and certain assets of Gem Certification & Assurance Lab, Inc., a New York Corporation ("GCAL"), comprising the gemological laboratory business of GCAL, through GCAL USA LLC, a newly created Delaware, USA entity ("GCAL USA") which is 70% owned by the Purchaser and 30% owned by GCAL. Under the Agreement the total purchase price paid by the Purchaser was US\$ 5.65 million in cash for a 70% interest in the business.
By implementing the Group's unique technologies and products, the Group will be able to concurrently develop its services globally while significantly expanding its services to U.S. retailers and wholesalers. The acquisition will provide the Group with a well respected channel into the U.S. market and accelerate its penetration thereof.
The Agreement contains two put/call arrangements. The first would be appliable in the event of a change in control of Sarine in the event the proposed acquirer seeks control over 100% of the equity interests in GCAL USA or if Seller seeks to dispose of its interest in GCAL USA to the proposed acquirer. The second put/call arrangement is applicable following the third anniversary of the Completion and enables Sarine to acquire all of Seller's equity in GCAL USA or Seller to dispose of its interest in GCAL USA to Sarine (the "Put/Call"). The purchase price for the Put/Call, if exercised by Sarine, is the greater of (a) Seller's equity interest in GCAL USA multiplied by \$8.5 million and (b) a multiple of eight times the trailing eight quarters' average annual net income of GCAL USA (the "Call Option Exercise Price"). If exercised by Seller, the purchase price is six times the multiple of the trailing eight quarters' average annual net income of GCAL USA (the "Put Option Exercise Price").
The Company applied the anticipated-acquisition method and accounts for 100% of GCAL USA in its financial statements from day one.
Details of the purchase consideration, the net assets acquired and goodwill are as follows:
Purchase consideration (US\$ thousands)
| Cash paid | 5,650 |
|---|---|
| Tax paid | 45 |
| Fair value of Put Option Exercise Price* | 1,727 |
| Total purchase consideration | 7,422 |
* Valuation of options granted as part of the asset purchase agreement.
The assets and liabilities recognised as a result of the acquisition are as follows (US\$ thousands):
| Property, plant and equipment | 1,220 |
|---|---|
| Customers relations | 1,825 |
| Brand name | 699 |
| Goodwill | 3,076 |
| Fair value of Call Option exercise price | 602 |
| Total purchase consideration | 7,422 |
(i) Presented hereunder is information regarding the techniques the Group used to measure the fair value of the assets and liabilities recognised as a result of the business combination:
The fair value of fixed assets is based on market values. The market value of fixed assets is the estimated amount for which a fixed asset could be exchanged on the date of valuation between a willing buyer and a willing seller in an arm's length transaction wherein the parties each acted knowledgeably. The market value of items of plant, equipment, fixtures and fittings is based on quoted market prices for similar items, when available, and on replacement costs when such quotes are unavailable.
The fair value of Brand name is based on the discounted estimated royalty payments that have been avoided as a result of the trademark being owned. The fair value of customer relationships is determined using the multi-period excess earnings method, whereby the subject asset is valued after deducting a fair return on all other assets that are part of creating the related cash flows.
If new information is obtained within one year from the acquisition date about facts and circumstances that existed at the acquisition date, the Group will retrospectively adjust the relevant amounts that were recognised at the time of the acquisition.
The goodwill is attributable mainly to the skills and technical talent of the acquiree's work force, and the synergies expected to be achieved from integrating the company into the Group's existing regular business.
The Group incurred acquisition-related costs of approximately US\$ 0.3 million related to legal fees and due diligence costs. These costs have been included in general and administrative expenses in the statement of profit or loss and other comprehensive income.
During January 2024 the Company completed an off-market equal access share buy back scheme in which the Company purchased 3,999,874 shares at 25.4 cents US\$ (34 Singapore cents) per share.
In Q1 2024, the GCAL by Sarine LGD grading lab in Surat, India commenced operation, our new MVP rough diamond optimization pay-per-stone service for very small stones was commercially launched, as was our pay-percarat service facilitating the optimal rough planning of large LGD.
These figures have not been audited or reviewed. The figures presented were prepared in accordance with International Financial Reporting Standards (IFRS).
Not applicable.
The same accounting policies and methods of computation adopted in the most recently audited financial statements for the financial year ended December 31, 2022 have been applied in the preparation for the financial statements for the financial year ended December 31, 2023.
Not applicable.
5. Net asset value (for the issuer and group) per ordinary share based on issued share capital of the issuer at the end of the:
(a) current financial period reported on; and
(b) immediately preceding financial year.
| Group December 31, |
Company December 31, |
||||
|---|---|---|---|---|---|
| 2023 | 2022 | 2023 | 2022 | ||
| Net asset value (US\$ thousands) | 60,320 | 67,096 | 60,320 | 67,096 | |
| Net asset value per ordinary share: | |||||
| US cents Singapore cents* |
17.35 22.88 |
19.23 25.36 |
17.35 22.88 |
19.23 25.36 |
At December 31, 2023, net asset value per share is calculated based on the number of ordinary shares in issue at December 31, 2023 of 347,744,435 (not including 9,067,900 dormant ordinary shares at December 31, 2023). At December 31, 2022, net asset value per share is calculated based on the number of ordinary shares in issue at December 31, 2022 of 348,938,195 (not including 7,509,700 dormant ordinary shares at December 31, 2022).
* Convenience translation based on exchange rate of US\$ 1=S\$ 1.3186 at December 31, 2023.
6. A review of the performance of the group, to the extent necessary for a reasonable understanding of the group's business:-
(a) any significant factors that affected the turnover, costs, and earnings of the group for the current financial period reported on, including (where applicable) seasonal or cyclical factors; and (b) any material factors that affected the cash flow, working capital, assets or liabilities of the group during the current financial period reported on.
During 2023 the diamond industry again faced significant macroeconomic headwinds, as well as disruption by the LGD segment.
Interest rates negatively affected the key U.S. market for much of the year, until positive inflation reduction data emerged, pausing the rate increases, reducing prospects of a subsequent recession and raising expectations for eventual easing. Indeed, consumer confidence was buoyed in the critical year-end holiday season, with overall holiday spending some 5% higher year over year. In the second most important market for diamond jewellery, China, ongoing negative macroeconomic conditions, relating primarily to the real-estate market, ensued. Related fears of possible banking insolvencies did, in fact, drive Chinese consumers to prefer spending on gold, the historical safe haven, rather than on diamond jewellery.
On top of these issues the disruption caused by the rapid growth of the LGD segment in the U.S. market, which started in 2022, apparently peaked in 2023. Towards year's end the upwards trend of LGD adoption slowed significantly. We attribute this to the sustained drop in LGD production costs (down to US\$ 100-150 for a one carat stone) and the propagation of this to the wholesale prices (US\$ 300-400) and now to retail prices, as well – Walmart offered a one carat quality LGD for US\$ 599, a 1.5 carat stone for US\$ 699 and 2 carat stones also for under US\$ 1,000 during the holiday season. If during 2022 and most of 2023 LGD sold at retail for about 50% of the cost of a natural stone, even though the wholesale price was already some 90% less, the disparity is, finally, closing. Though DeBeers had launched its Lightbox LGD for US\$ 800 for a one carat stone, its retail presence was not sufficient to establish this price as the norm. Walmart offering LGD at these prices is much more significant, it being the second largest retailer of diamond jewellery in North America. We believe that this new retail price range, and the dramatic drop from previously touted pricing in the span of a year, may have affected consumer appetite for LGD, especially for bridal jewellery and engagement rings. Though it is still too early to assess if this is a new trend, or a temporary lull, this may indicate that the natural diamond and LGD segments of the diamond jewellery market are reaching a new equilibrium, as had been forecast by various industry analysts.
Polished natural diamond prices eroded for most of the year, commencing early in the year through to October, as the aforementioned combined headwinds and LGD disruption took their toll. Prices of rough natural diamonds for the most part stayed steady, as DeBeers did not reduce prices in 2023 (notably, at the DeBeers January 2024 sight, rough diamond prices were very significantly reduced by 15-20%). Firm rough prices and decreasing polished prices impaired margins for our midstream customers. Towards the end of 2023, Indian manufacturers declared a selfimposed two-month moratorium on the import of rough diamonds. The final two DeBeers sights in November and December 2023 were a scant US\$ 86 and 137 million, respectively. For the year, DeBeers sales dropped a very significant 40%, which led to appropriately reduced midstream polishing activity, more significantly so in the second half of the year.
In May 2023 the Group closed its acquisition of the business and certain assets of the Gem Certification & Assurance Lab, Inc. (GCAL), pursuant to which the Group acquired a 70% stake in the gemmological laboratory business of GCAL, through GCAL USA LLC.
The Group reported in H2 2023, revenues of US\$ 19.2 million, loss from operations of US\$ 3.2 million, and net loss of US\$ 3.8 million, as compared to revenues of US\$ 27.6 million, profit from operations of US\$ 3.5 million, and net profit of US\$ 2.3 million reported in H2 2022. For the year ended December 31, 2023, the Group recorded revenues of US\$ 42.9 million, loss from operations of US\$ 1.8 million and net loss of US\$ 2.8 million, as compared to revenues of US\$ 58.8 million, profit from operations of US\$ 11.0 million and net profit of US\$ 8.8 million for the year ended December 31, 2022.
Overall revenues declined in H2 2023 and for the year in review, as compared to H2 2022 and FY2022, on decreased capital equipment sales following the aforementioned issues, partly offset by increased recurring revenues due to the acquisition of GCAL.
The decline in profitability in H2 2023 and for the year was due to lower sales and lower gross profit margin, offset somewhat by an overall decline in operating expenses.
Overall recurring revenues for H2 2023 (including Galaxy® inclusion scanning, polished diamond related services, annual maintenance contracts, etc.) were approximately 71% of our overall revenue (approximately 66% for all of FY2023). Overall rough and polished diamond wholesale and retail related ("Trade") revenues, mostly from Grading, digital tenders, the Sarine Profile™ and the Sarine Diamond Journey™ were approximately 31% of our overall revenue for H2 2023 (approximately 23% for all of FY2023), the increase attributed mainly to the acquisition of GCAL. We expect Trade revenues to continue growing in FY2024 from expansion of our grading services and adoption of our new pay-per-use services for natural and LGD stones optimal planning.
The Group delivered 7 Galaxy®-family inclusion mapping systems in H2 2023, of which two systems were sold under the one-off paradigm with no follow-on per-use revenues to be generated from them in the future. As of December 31, 2023, our installed base was 830 systems.
As at December 31, 2023, cash, cash equivalents, short-term investments (bank deposits) ("Cash Balances") declined to US\$ 23.0 million as compared to US\$ 36.0 million as of December 31, 2022. The Cash Balances were primarily affected by the payment of US\$ 4.4 million in dividends (an interim US\$ 0.9 million dividend in September 2023 and a US\$ 3.5 million final FY2022 dividend in May 2023), the acquisition of GCAL for US\$ 5.7 million, the repurchase of US\$ 0.4 million of Sarine shares in the open market, acquisition of fixed assets of US\$ 1.5 million and the net cash used in operating activities of US\$ 1.0 million.
Our revenues for H2 2023 of US\$ 19.2 million, declined by 30%, as compared to revenues of US\$ 27.6 million reported in H2 2022. The overall decline in revenues, was due to an approximate 62% decrease in capital equipment sales due to aforementioned issues, offset by an approximate 4% increase in recurring revenues, due to the addition of GCAL, as discussed above. Revenues for the year ended December 31, 2023 of US\$ 42.9 million, declined by 27%, as compared to US\$ 58.8 million for the year ended December 31, 2022. The year-over-year decrease in revenues, was due to an approximate 50% decrease in capital equipment sales and an approximate 3% decrease in recurring revenues, due to negative industry conditions for most of FY2023, as discussed above.
Cost of sales for H2 2023 of US\$ 8.1 million, declined by 12% (on a decline in revenues of 30%), as compared to US\$ 9.2 million in H2 2022, with a gross profit margin of 58% in H2 2023 compared to 67% in H2 2022. The decline in the cost of sales in H2 2023 was primarily due to lower capital equipment sales offset by increased costs related to GCAL's operations. The decline in the gross profit margin were primarily due to lower capital equipment sales the revenue from GCAL at lower gross profit margins.
Cost of sales for the year ended December 31, 2023 of US\$ 15.6 million, declined by 14% (on a decrease in revenues of 27%), as compared to US\$ 18.1 million for the year ended December 31, 2022, with a gross profit margin of 64% in FY2023 compared to 69% in FY2022. The decrease in cost of sales in FY2023 was primarily due to lower capital equipment sales and product mix. The decrease in gross profit and the corresponding decrease in gross profit margin were primarily due to decreased overall sales and product mix, mainly the inclusion of GCAL.
Research and development expenses for H2 2023 of US\$ 4.2 million were 6% less than the US\$ 4.5 million in H2 2022. Research and development expenses for the year ended December 31, 2023 of \$8.6 million were on par with the US\$ 8.7 million for the year ended December 31, 2022.
Sales and marketing expenses for H2 2023 of US\$ 6.3 million, increased by 1%, as compared to US\$ 6.2 million in H2 2022. Sales and marketing expenses for the year ended December 31, 2023 of US\$ 12.8 million were increased by 3% as compared to US\$ 12.4 million in year ended December 31, 2022.
General and administrative expenses for H2 2023 of US\$ 3.9 million, decreased by 9%, as compared to US\$ 4.2 million in H2 2022. General and administrative expenses for the year ended December 31, 2023 of US\$ 7.8 million, decreased by 9%, as compared to US\$ 8.5 million for the year ended December 31, 2022. The decline in general and administrative expenses was primarily due to less incentive-based compensation and third-party legal and professional fees related to ongoing multiple patent and copyright litigations and related activities in India.
The Group reported a loss from operations of US\$ 3.2 million in H2 2023, as compared to US\$ 3.5 million profit in H2 2022, and a loss of US\$ 1.8 million for the year ended December 31, 2023, as compared to a profit of US\$ 11.0 million for the year ended December 31, 2022. The decline in profit from operations in H2 2023 was mainly due to lower sales, resulting in a lower gross profit (gross profit margin impaired by lower capital equipment sales combined with the inclusion of GCAL), offset slightly by an overall decrease in operating expenses. The decline in profitability for FY 2023 was also impacted by overall lower sales in FY2023, as detailed above.
Net finance income for H2 2023 was US\$ 0.2 million as compared to US\$ 0.3 million in H2 2022. Net finance income for the year ended December 31, 2023 was US\$ 0.6 million as compared to US\$ 0.3 million for the year ended December 31, 2022. The increase in net finance income was due to higher overall interest income during FY2023 as compared to FY2022.
The Group recorded an income tax expense of US\$ 0.7 million for H2 2023 as compared to US\$ 1.5 million in H2 2022. The Group recorded an income tax expense of US\$ 1.5 million for the year ended December 31, 2023, as compared to US\$ 2.5 million for the year ended December 31, 2022. The Group's income tax is affected by the profitability being realised in various entities of the Group, each subject to different jurisdictions, applicable incentives, and income tax loss carry forwards.
The Group reported a loss of US\$ 3.8 million in H2 2023, as compared to a profit of US\$ 2.3 million in H2 2022, and a loss of US\$ 2.8 million for the year ended December 31, 2023 as compared to a profit of US\$ 8.8 million for the year ended December 31, 2022. The decrease in net profit was mainly due to lower profit from operations, as detailed above.
7. Where a forecast, or a prospect statement, has been previously disclosed to shareholders any variance between it and the actual results.
Not applicable.
We expect the following industry trends to continue influencing our business:
about 50% of the cost of a natural stone even though the wholesale price was already some 90% less, this disparity is, finally, closing. We believe that it is this new retail price range, and the dramatic drop from previously accepted pricing in the span of a year, that may have affected consumer appetite for LGD, especially for bridal jewellery and engagement rings. Though it is still too early to assess if this is a new trend, or a temporary lull, this may indicate that the natural diamond and LGD segments of the diamond jewellery market are reaching a new equilibrium. We have facilitated the utilisation of our rough planning technologies on LGD. There is an estimated 20 million carats annual production of LGD, and our initial tests realised an average added value to the manufacturer of US\$ 1.5 per carat. Commercial services have commenced with our launch customer, a major supplier of LGD, based on a pay per carat business model. We have similarly adapted our AI-derived grading technologies to LGD and have integrated them into GCAL's work procedures. Our LGD focused GCAL by Sarine grading lab in Surat, India, commenced operations in January. The total addressable market (TAM) for LGD grading is estimated as having been in excess of US\$ 100 million in 2023. Our aim is to capture 8-10% of this market in 2024.
None.
On February 26, 2023, the Board of Directors recommended that the Annual General Meeting (AGM) approve a final dividend of US 1.0 cent per ordinary share for the financial year ended December 31, 2022.
(c) Whether the dividend is before tax, net of tax or tax exempt. If before tax or net of tax, state the tax rate and the country where the dividend is derived.
| Tax rate applicable | ||
|---|---|---|
| Amount before tax | to shareholders | |
| US\$ thousands | Percent | |
| 2022 | 3,489 | 20%/0%1 / 10%2,3 |
1 The tax rate in 2022 was 20% for individual Israeli shareholders and 0% for Israeli corporate shareholders.
2The tax rate in 2022 for the dividends for individual and corporate Singaporean shareholders was 10%. 3 Payments to shareholders of dividends distributed by the Company will be subject to a tax deduction at source at the rate of 20%, in compliance with Israeli tax directives. Tax amounts deducted from dividend payments will be deposited with a trustee. A shareholder claiming eligibility for preferential tax treatment on dividend payments pursuant to Israeli tax laws or international tax treaties may apply to the trustee within 30 days of the distribution date providing all necessary details and documents, for reimbursement of excess deduction, subject to verification of such eligibility. Details regarding the application procedure shall be provided by the Company in the formal dividend announcement posted on the SGX.
| Amount | |
|---|---|
| US\$ thousands | |
| 12 May 2023 | 3,489 |
5:00 PM on:
| Amount | |
|---|---|
| US\$ thousands | |
| 02 May 2023 | 3,489 |
No dividend has been recommended. The Group's stated dividend policy is to distribute 80% its net profits. With the deteriorating industry conditions in mind, a cautious interim dividend of US cents 0.25 cents per share was paid in September 2023 based on 1H2023 results. As the second half's results do in fact show a loss, culminating in a loss for the entire year, due to the issues discussed above, there is no justification for a final dividend.
The Group has not obtained a general mandate from its shareholders for IPTs.
Not applicable.
The Company confirms that it has procured undertakings from all its Directors and Executive Officers in the format set out in Appendix 7.7 under Rule 720 (1) of the Listing Manual.
In accordance with IFRS 8 Operating Segments, the Group determines and presents operating segments based on the information that internally is provided to the CEO, who is the Group's chief operating decision maker. The Group operates in only one operating segment. Presented below are revenues broken out by geographic distribution.
| India | Africa | Europe | USA | Israel | Others | Consolidated | |
|---|---|---|---|---|---|---|---|
| 2023 | |||||||
| US\$ thousands | |||||||
| External revenues | 22,036 | 6,336 | 2,730 | 5,147 | 1,803 | 4,892 | 42,944 |
| Unallocated expenses | (44,788) | ||||||
| Loss from operations | (1,844) | ||||||
| Net finance income | 576 | ||||||
| Income tax expense | (1,534) | ||||||
| Loss for the year | (2,802) | ||||||
| India | Africa | Europe | USA | Israel | Others | Consolidated | |
| 2022 | |||||||
| US\$ thousands | |||||||
| External revenues | 30,309 | 13,692 | 3,502 | 842 | 2,227 | 8,191 | 58,763 |
| Unallocated expenses | (47,765) | ||||||
| Profit from operations | 10,998 | ||||||
| Net finance expense | 337 | ||||||
| Income tax expense | (2,537) | ||||||
| Profit for the year | 8,798 | ||||||
15. In the review of performance, the factors leading to any material changes in contributions to turnover and earnings by the business or geographical segments.
See section 6 above.
| 2023 | 2022 | ||
|---|---|---|---|
| US\$ thousands | |||
| Revenue reported for: | |||
| First half-year ended 30 June | 23,731 | 31,172 | |
| Second half-year ended 31 December | 19,213 | 27,591 | |
| 42,944 | 58,763 | ||
| Profit (loss) for the period: | |||
| First half-year ended 30 June | 953 | 6,545 | |
| Second half-year ended 31 December | (3,755) | 2,253 | |
| (2,802) | 8,798 |
17. A breakdown of the total annual dividend (in US dollar value) for the issuer's latest full year and its previous full year.
| Latest Full Year | Previous Full Year |
|---|---|
| US\$ thousands | |
| 872 | 10,492 |
18. Disclosure of person occupying a managerial position in the issuer or any of its principal subsidiaries who is a relative of a director or chief executive officer or substantial shareholder of the issuer pursuant to Rule 704(13)
The Company confirms that, during the year ended December 31, 2023, there was no person occupying any managerial position in the Company or any of its subsidiaries who is a relative of a director or chief executive officer or substantial shareholder of the Company.
The Company confirms that during the year ended December 31, 2023, the Company was not a party to any interested person transactions.
On behalf of the Directors
Daniel Benjamin Glinert Executive Chairman
25 February 2024
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.